Literature DB >> 2275885

Electrophysiologic evaluation of antiarrhythmic drugs.

P Touboul1.   

Abstract

Electrophysiologic techniques are used to assess the properties of antiarrhythmic drugs and also to provide support for the selection of antiarrhythmic therapy for individual patients. Assessment of the antiarrhythmic efficacy of drugs requires that the arrhythmia can be induced by programmed electrical stimulation and is critically dependent on the stimulation protocol. Continued inducibility on drug therapy appears to be a strong predictor of recurrences and sudden death, although the predictive value of electrophysiologic testing remains controversial for some drugs. These techniques may also be useful for determining the proarrhythmic potential of antiarrhythmic agents, but the aggravation of tachycardia that occurs in 10-30% of patients during electrophysiologic testing is unpredictable and its significance is unknown. The electrophysiologic approach to drug therapy has limitations, but, nevertheless, it is useful and should maintain a prominent place in the evaluation of antiarrhythmic therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275885     DOI: 10.1007/bf00357025

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  8 in total

Review 1.  Pharmacologic therapy of ventricular tachycardia using electrophysiologic techniques.

Authors:  S P Kutalek
Journal:  Cardiol Clin       Date:  1986-08       Impact factor: 2.213

2.  The arrhythmogenicity of antiarrhythmic agents.

Authors:  V Torres; D Flowers; J C Somberg
Journal:  Am Heart J       Date:  1985-05       Impact factor: 4.749

3.  Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.

Authors:  H J Wellens; F W Bär; W R Dassen; P Brugada; E J Vanagt; J Farré
Journal:  Am J Cardiol       Date:  1980-10       Impact factor: 2.778

4.  Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.

Authors:  R F Poser; P J Podrid; F Lombardi; B Lown
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

5.  Determinants of survival in patients with ventricular tachyarrhythmias.

Authors:  C D Swerdlow; R A Winkle; J W Mason
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

6.  Effects of intravenous sotalol in patients with atrioventricular accessory pathways.

Authors:  P Touboul; G Atallah; G Kirkorian; P Lavaud; M P Mathieu; A Dellinger
Journal:  Am Heart J       Date:  1987-09       Impact factor: 4.749

7.  Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol?

Authors:  H J Wellens; P Brugada; W G Stevenson
Journal:  Circulation       Date:  1985-07       Impact factor: 29.690

8.  Electrophysiological action of bepridil on atrioventricular accessory pathways.

Authors:  P Touboul; G Atallah; G Kirkorian; P Lavaud; J R Kieny; M P Mathieu; A Dellinger
Journal:  Br Heart J       Date:  1987-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.